Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Quoin Pharmaceuticals Ltd DRC (QNRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Quoin Pharmaceuticals DRC's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.7200 -0.0131    -1.79%
16:00:29 - Closed. Currency in USD ( Disclaimer )
After Hours
0.7188
-0.0012
-0.17%
18:04:58 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 10,031
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.7100 - 0.7372
Quoin Pharmaceuticals DRC 0.7200 -0.0131 -1.79%

Quoin Pharmaceuticals Ltd DRC Company Profile

 
Get an in-depth profile of Quoin Pharmaceuticals Ltd DRC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

4

Equity Type

ADR

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.

Contact Information

Address 42127 Pleasant Forest Court
Ashburn, 20148-7349
United States
Phone 703 980 4182
Fax -

Top Executives

Name Age Since Title
Dennis H. Langer 71 2021 Independent Director
Michael Myers 61 2018 Co-Founder, CEO & Chairman
Amy Paller - - Scientific Advisor
Natalie Leong 37 2021 Independent Director
Alan Irvine - - Scientific Advisor
Denise Carter 54 2018 Co-Founder, COO & Director
Michael T. Sember 73 2021 Independent Director
James Culverwell 66 2021 Independent Director
Joseph P. Cooper 65 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

QNRX Comments

Write your thoughts about Quoin Pharmaceuticals Ltd DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bdrxadtx Mullen
Bdrxadtx Mullen Dec 15, 2023 1:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
do not buy
Bdrxadtx Mullen
Bdrxadtx Mullen Oct 18, 2023 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$8$
Ayhan Batu
Ayhan Batu Oct 02, 2023 1:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how much further fall
Ayhan Batu
Ayhan Batu Aug 25, 2023 3:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i think this stock 100$
matanel liberman
matanel liberman Jul 21, 2023 10:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
18 soon
Nhat Doan
Nhat Doan Dec 29, 2022 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TEST CAN NOT SHORT 👉 Never BUY 👍👌👹
David Steren
David Steren Dec 11, 2022 9:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to rise
Magdy Elsirsy
Magdy Elsirsy Aug 11, 2022 8:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do u think guys it will go down more so better to sell ??
pratik patel
pratik patel Aug 05, 2022 9:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I m in 66%
matanel liberman
matanel liberman Dec 17, 2021 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Back to 5
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email